Book a Meeting

Anti-Tudor domain-containing protein 3 Antibody, Non-Fucosylated (BioBet-1327ZP) (CAT#: BioBet-1327ZP) Datasheet

Target
Tudor domain-containing protein 3
Isotype
IgG
Description
Anti-Tudor domain-containing protein 3 Antibody, Non-Fucosylated (BioBet-1327ZP) is a mouse monoclonal IgG antibody against Tudor domain-containing protein 3. This product is an ADCC enhanced antibody produced by our Afuco™ platform.
Antibody Indication
Breast Cancer
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced Tudor domain-containing protein 3 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
TDRD3
Full Name
tudor domain containing 3
Alternative Names
TDRD3; tudor domain containing 3; tudor domain-containing protein 3
Gene ID
81550
Cellular Localization
Nucleus
Involvement in Disease
Diseases associated with TDRD3 include Fragile X Syndrome and Chromosome 22Q11.2 Deletion Syndrome, Distal.
Related Pathways
Its related pathways are Chromatin Regulation / Acetylation and Translational Control.
Function
Scaffolding protein specifically recognizes and binds proteins containing dimethyl larginine. In the nucleus, it acts as a co-activator: it recognizes and binds to the asymmetric dimethylation (H3R17me2a and H4R3me2a) of the core histone tail associated with transcriptional activation, and recruits proteins at these arginine methylation sites. In the cytoplasm, it may participate in the assembly and/or disassembly of mRNA stress particles, and regulate the translation of target mRNA by binding to the Arg/gly-rich motif (GAR) in the protein containing dimethyllarginine.
Post-translational modifications
1.Modification sites at neXtProt 2.Modification sites at PhosphoSitePlus
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG
Antibody Clone
BioBet-1327ZP
Host
Mouse
Species Reactivity
Human
Description
The antibodues binding the Tudor domain-containing protein 3 (TDRD3) can be used to treat breast cancers.
Antibody Indication
Breast Cancer

Breast Cancer

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.